The Department of Veterans Affairs requires molecular testing of indeterminate thyroid nodule FNA specimens to stratify patients for surgical necessity, with an estimated annual volume of 120 tests at the VA Puget Sound Health Care System in Seattle. The contractor must provide a CLIA-certified laboratory offering a test with high specificity and sensitivity for malignancy, detecting mutations including BRAF, RAS, TERT, RET, NTRK, and ALK, with a turnaround time of seven business days. The contractor supplies transport media, packaging, and overnight shipping labels, and must have experience performing thyroid molecular testing for other VA laboratories. The base period of performance runs from October 1, 2026, to August 31, 2027, with four optional one-year extensions through August 31, 2031. Work will be performed at the contractor’s facility.

The government requires molecular testing of indeterminate thyroid nodule FNA specimens for the VA Puget Sound Health Care System in Seattle. Testing will be performed at an outside laboratory, with specimens shipped using contractor-provided transport media and shipping materials. The annual volume is approximately 120 molecular tests per year. No specific budget amounts or submission timelines are mentioned in the description. Performance of services is specified for the VA Puget Sound Health Care System in Seattle.